116 related articles for article (PubMed ID: 31125280)
1. Lenalidomide-induced tubulointerstitial nephritis in Hodgkin lymphoma.
Dinh A; Palmer MB; Svoboda J; Hogan JJ
Leuk Lymphoma; 2019 Dec; 60(12):3084-3086. PubMed ID: 31125280
[No Abstract] [Full Text] [Related]
2. The evolving role of lenalidomide in non-Hodgkin lymphoma.
Galanina N; Petrich A; Nabhan C
Leuk Lymphoma; 2016 Jul; 57(7):1507-16. PubMed ID: 26902680
[TBL] [Abstract][Full Text] [Related]
3. Transient atelectasis due to hilar lymph node swelling affected by lenalidomide-induced tumor flare reaction.
Suyama T; Yui T; Horiuchi A; Irie R; Osamura Y; Miyao N
J Clin Exp Hematop; 2021 Mar; 61(1):48-52. PubMed ID: 33431741
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP.
Boland PJ; Hegerova LT; Williams SJ; McKenna RW; Bachanova V; Eckfeldt CE
Leuk Lymphoma; 2017 Feb; 58(2):478-481. PubMed ID: 27339158
[No Abstract] [Full Text] [Related]
5. IVIG-triggered tubulointerstitial nephritis in X-linked agammaglobulinemia.
Takeguchi M; Korematsu S; Miyahara H; Kuga S; Izumi T
Pediatr Int; 2017 Aug; 59(8):945-946. PubMed ID: 28707726
[No Abstract] [Full Text] [Related]
6. Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients.
Aitmehdi R; Arnaud L; Francès C; Senet P; Monfort JB; de Risi-Pugliese T; Barbaud A; Cohen-Aubart F; Haroche J; Pha M; Hie M; Le Guern V; Costedoat-Chalumeau N; Mékinian A; Fain O; Mathian A; Amoura Z; Chasset F
J Am Acad Dermatol; 2021 Apr; 84(4):1171-1174. PubMed ID: 33221461
[No Abstract] [Full Text] [Related]
7. Progressive Dysphagia in a Pregnant Woman.
Schechter M; Choi JJ; Culpepper-Morgan JA
Gastroenterology; 2017 Jan; 152(1):e12-e14. PubMed ID: 27893973
[No Abstract] [Full Text] [Related]
8. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Böll B; Plütschow A; Bürkle C; Atta J; Pfreundschuh M; Feuring-Buske M; Vogelhuber M; Sökler M; Eichenauer DA; Thielen I; von Tresckow B; Fuchs M; Engert A; Borchmann P;
Br J Haematol; 2019 Apr; 185(1):42-52. PubMed ID: 30592027
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme.
Drahy F; Ingen-Housz-Oro S; Grootenboer-Mignot S; Wolkenstein P; Chosidow O
JAMA Dermatol; 2018 Apr; 154(4):487-489. PubMed ID: 29450445
[No Abstract] [Full Text] [Related]
10. Challenging cases and diagnostic dilemmas: case 1. Tracheal compression in Hodgkin's disease.
Garrison MA; Glanton C; Rasnke M; Smith ME; Ornstein DL
J Clin Oncol; 2002 Aug; 20(15):3344-7. PubMed ID: 12149308
[No Abstract] [Full Text] [Related]
11. [Lenalidomide desensitization in a patient with 5q- syndrome].
Boudin L; Patient M; Roméo E; Bladé JS; de Jauréguiberry JP
Bull Cancer; 2017 Sep; 104(9):814-816. PubMed ID: 28778340
[No Abstract] [Full Text] [Related]
12. Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis.
Yamshon S; Christos PJ; Demetres M; Hammad H; Leonard JP; Ruan J
Blood Adv; 2018 Jun; 2(12):1429-1438. PubMed ID: 29934343
[TBL] [Abstract][Full Text] [Related]
13. Skin in a Hodgkin lymphoma.
Brahimi M; Attaf F; Arabi A; Bekadja MA
Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):68-70. PubMed ID: 23774179
[No Abstract] [Full Text] [Related]
14. B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.
Fürstenau M; Fink AM; Schilhabel A; Weiss J; Robrecht S; Eckert R; de la Serna J; Crespo M; Coscia M; Vitale C; Böttcher S; Weppner G; Ritgen M; Stilgenbauer S; Tausch E; Fischer K; Hallek M; Eichhorst B; Brüggemann M; Herling CD
Blood; 2021 Apr; 137(16):2267-2271. PubMed ID: 33512465
[No Abstract] [Full Text] [Related]
15. Unusual presentation of classic Hodgkin lymphoma.
Lyapichev KA; You MJ
Blood; 2019 Jan; 133(5):502. PubMed ID: 30705049
[No Abstract] [Full Text] [Related]
16. Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment.
Ma LY; Su L
Chin Med J (Engl); 2018 Oct; 131(20):2510-2513. PubMed ID: 30334543
[No Abstract] [Full Text] [Related]
17. Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide.
Chan TSY; Mak V; Kwong YL
Ann Hematol; 2017 Jul; 96(7):1211-1213. PubMed ID: 28432410
[No Abstract] [Full Text] [Related]
18. Complete remission following lenalidomide and rituximab in a patient with heavily pretreated nodular lymphocyte predominant Hodgkin lymphoma.
Cheah CY; Mistry HE; Konoplev S; Fowler NH
Leuk Lymphoma; 2016 Aug; 57(8):1974-6. PubMed ID: 26762971
[No Abstract] [Full Text] [Related]
19. Acute tubulo-interstitiel nephritis associated with diffuse large B-cell lymphoma presenting as acute renal failure.
Dede F; Yilmaz B; Ayli D; Kayataş M; Atilgan G; Caner S; Akyürek N; Odabaş AR
Ren Fail; 2008; 30(4):465-7. PubMed ID: 18569923
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
